| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INCY | Common Stock | Options Exercise | $480,340 | +7,000 | +16% | $68.62 | 49,835 | 26 Jan 2023 | Direct | |
| transaction | INCY | Common Stock | Sale | $595,000 | -7,000 | -14% | $85.00 | 42,835 | 26 Jan 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -7,000 | -100% | $0.000000* | 0 | 26 Jan 2023 | Common Stock | 7,000 | $68.62 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| F2 | Includes an aggregate of 40,178 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
| F3 | Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |